These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 19038908)
1. Digestion of the antiplatelets comparison of PRoFESS: 18-7=1? Algra A Stroke; 2009 May; 40(5):1932-5. PubMed ID: 19038908 [No Abstract] [Full Text] [Related]
2. Antiplatelets for stroke prevention: implications of the PRoFESS trial. Selim M Stroke; 2009 May; 40(5):1936-7. PubMed ID: 19038907 [No Abstract] [Full Text] [Related]
3. [Secondary stroke prevention according to the PRoFESS Study. What are the sequelae for practical therapy?]. Diener C MMW Fortschr Med; 2008 May; 150(21):7. PubMed ID: 18578065 [No Abstract] [Full Text] [Related]
4. Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with strokes: the Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS). Diener HC; Sacco R; Yusuf S; ; Cerebrovasc Dis; 2007; 23(5-6):368-80. PubMed ID: 17337887 [TBL] [Abstract][Full Text] [Related]
5. Is ticlopidine more effective than aspirin in preventing adverse cardiovascular events after myocardial infarction (MI)? Olson J; Huntington J J Fam Pract; 2001 Jul; 50(7):623. PubMed ID: 11485713 [No Abstract] [Full Text] [Related]
6. The PRoFESS trial results: what went wrong? Anderson CS Int J Stroke; 2008 Aug; 3(3):165-6. PubMed ID: 18705892 [No Abstract] [Full Text] [Related]
7. Regular or "super-aspirins"? A review of thienopyridines or aspirin to prevent stroke. Ernst ME J Am Geriatr Soc; 2001 Apr; 49(4):487-9. PubMed ID: 11347797 [No Abstract] [Full Text] [Related]
8. ProFESS trial: any lessons to learn for future anti-platelet trials? Sharma JC; Vassallo M; Ross IN Int J Stroke; 2009 Dec; 4(6):458-60. PubMed ID: 19930057 [No Abstract] [Full Text] [Related]
9. Secondary stroke prevention set to benefit from PRoFESS trial: extended-release dipyridamole plus aspirin (Asasantin Retard) and clopidogrel share very similar benefit-risk ratio in vascular prevention. Cardiovasc J Afr; 2008; 19(3):165. PubMed ID: 18568182 [No Abstract] [Full Text] [Related]
10. Effect of combined aspirin and extended-release dipyridamole versus clopidogrel on functional outcome and recurrence in acute, mild ischemic stroke: PRoFESS subgroup analysis. Bath PM; Cotton D; Martin RH; Palesch Y; Yusuf S; Sacco R; Diener HC; Estol C; Roberts R; Stroke; 2010 Apr; 41(4):732-8. PubMed ID: 20181679 [TBL] [Abstract][Full Text] [Related]